Literature DB >> 22383442

Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain.

Jesús Oteo1,2, Diego Domingo-García3, Sara Fernández-Romero2, David Saez2, Alba Guiu3, Oscar Cuevas2, Manuel Lopez-Brea3, José Campos4,1,2.   

Abstract

We describe a clinical case of an abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in a 35-year-old Spanish patient after hospitalization in India for perforated appendicitis and peritonitis. The strain belonged to the MLST type 231 and had multiple additional antibiotic resistance genes such as bla(CTX-M-15), armA methylase, aac(6')-Ib-cr, dfrA12, sul1 and qnrB and lack of porin genes ompK35 and ompK36. The patient was cured after abscess drainage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22383442     DOI: 10.1099/jmm.0.043190-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

Review 1.  Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.

Authors:  Vindana Chibabhai; Trusha Nana; Norma Bosman; Teena Thomas; Warren Lowman
Journal:  Infection       Date:  2017-09-15       Impact factor: 3.553

2.  Carbapenemase-producing enterobacteriaceae in Spain in 2012.

Authors:  Jesús Oteo; David Saez; Verónica Bautista; Sara Fernández-Romero; Juan Manuel Hernández-Molina; María Pérez-Vázquez; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

3.  Molecular characterization of blaNDM-5 carried on an IncFII plasmid in an Escherichia coli isolate from a nontraveler patient in Spain.

Authors:  Cristina Pitart; Mar Solé; Ignasi Roca; Angely Román; Asunción Moreno; Jordi Vila; Francesc Marco
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

4.  In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.

Authors:  Dora E Wiskirchen; Patrice Nordmann; Jared L Crandon; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

Review 5.  Epidemiology of carbapenemase-producing Enterobacteriaceae and Acinetobacter baumannii in Mediterranean countries.

Authors:  Nassima Djahmi; Catherine Dunyach-Remy; Alix Pantel; Mazouz Dekhil; Albert Sotto; Jean-Philippe Lavigne
Journal:  Biomed Res Int       Date:  2014-05-13       Impact factor: 3.411

6.  Outbreak of plasmid-mediated NDM-1-producing Klebsiella pneumoniae ST105 among neonatal patients in Yunnan, China.

Authors:  Rui Zheng; Qian Zhang; Yidan Guo; Yue Feng; Li Liu; Amei Zhang; Yue Zhao; Xiaoyu Yang; Xueshan Xia
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-02-19       Impact factor: 3.944

7.  Evaluation of the Xpert Carba-R (Cepheid) Assay Using Contrived Bronchial Specimens from Patients with Suspicion of Ventilator-Associated Pneumonia for the Detection of Prevalent Carbapenemases.

Authors:  Almudena Burillo; Mercedes Marín; Emilia Cercenado; Guillermo Ruiz-Carrascoso; María Jesús Pérez-Granda; Jesús Oteo; Emilio Bouza
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

8.  Ertapenem non-susceptibility and independent predictors of the carbapenemase production among the Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).

Authors:  Shio-Shin Jean; Wen-Sen Lee; Po-Ren Hsueh
Journal:  Infect Drug Resist       Date:  2018-10-17       Impact factor: 4.003

Review 9.  Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics.

Authors:  Monika T Zmarlicka; Michael D Nailor; David P Nicolau
Journal:  Infect Drug Resist       Date:  2015-08-24       Impact factor: 4.003

Review 10.  Epidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean Countries.

Authors:  Corrado Girmenia; Alessandra Serrao; Martina Canichella
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-07-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.